Innospec Q2 2024 Adj. EPS $1.39 Beats $1.37 Estimate, Sales $435.000M Miss $480.400M Estimate
Portfolio Pulse from Benzinga Newsdesk
Innospec (NASDAQ:IOSP) reported Q2 2024 adjusted EPS of $1.39, beating the analyst estimate of $1.37. However, the company missed sales estimates, reporting $435 million against the expected $480.4 million, a 9.45% decrease from the same period last year.
August 06, 2024 | 8:45 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Innospec's Q2 2024 adjusted EPS of $1.39 beat estimates, but sales of $435 million missed expectations and were down 9.45% year-over-year.
While the EPS beat is a positive sign, the significant miss on sales and the year-over-year decline in revenue could weigh on investor sentiment, leading to a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100